COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia is a research paper published in Leukemia (2021). On theSindex it has a DataRank of 0. It has been cited 156 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P30 CA008748
NCI NIH HHS
Grant: K08 CA248966
National Institutes of Health
Grant: 1K08CA248966-01
Fc-enhanced CD40 agonist antibodies for immune modulation of the tumor microenvironment
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Additional file 1 of Serologic response following SARS-COV2 vaccination in patients with cancer: a systematic review and meta-analysis
Additional file 1 of Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2
Additional file 1 of Nano-carrier DMSN for effective multi-antigen vaccination against SARS-CoV-2
Additional file 2 of IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
Additional file 2 of IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
Additional file 1 of IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients
Additional file 1 of IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients